Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma

Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma

In metastatic renal cell carcinoma, complete response to first-line antiangiogenic agents is rare and resistance to therapy often develops. Protocols for sequential treatment with angiogenesis and mTOR inhibitors are under evaluation to improve outcomes. In this observational, real-world study, pati...

Full description

Bibliographic Details
Main Authors: Sabrina Rossetti, Carmine D'Aniello, Gelsomina Iovane, Sarah Scagliarini, Maria M. Laterza, Fernando De Vita, Clementina Savastano, Giacomo Cartenì, Maria A. Porricelli, Massimiliano Berretta, Salvatore Pisconti, Gaetano Facchini, Carla Cavaliere
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-07-01
Series:Frontiers in Pharmacology
Subjects:
metastatic renal carcinoma
pazopanib
everolimus
sequential therapy
real-world
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00484/full

Internet

http://journal.frontiersin.org/article/10.3389/fphar.2017.00484/full

Similar Items